5/27/2004: Thinking About Drug Price Controls (Steven Pearlstein in The Washington Post; subscription may be required)

Excerpt: Washington Post columnist Steven Pearlstein was online to talk about whether the government should study the cost-effectiveness of new medicines and then use that information to determine how much Medicare should pay drugmakers. In his column today, Pearlstein concludes: 'The question isn't whether we'll ration and manage, but who will do it and how. And sooner we start talking about it openly, the better things will turn out.'